Exudative Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Exudative Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: A Multi-Center, Open Label, Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular Degeneration [Phase 2]
Phase 2 extension study evaluating additional intravitreal RBM-007 injections for wet age-related macular degeneration completed with posted…
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Efficacy and Safety of Intravitreal Conbercept With Modified Treat-and-Extend Regimens in Exudative AMD [Phase 2, Phase 3]
A trial update on intravitreal conbercept using modified treat-and-extend regimens for exudative age-related macular degeneration is being s…
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept [Phase 4]
Phase 4 trial update evaluating plasma VEGF levels before and after intravitreal aflibercept injection in exudative age-related macular dege…
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Intraocular Cytokine in Recurrence of Polypoidal Choroidal Vasculopathy [Phase 4]
A Phase 4 clinical trial update investigating intraocular cytokine therapy for recurrence of polypoidal choroidal vasculopathy, associated w…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: X-82 to Treat Age-related Macular Degeneration [Phase 2]
Phase 2 trial of X-82 for age-related macular degeneration has been terminated; results were posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)
A completed clinical trial evaluated the addition of 20 mg/day zeaxanthin to a triple-therapy regimen for exudative age-related macular dege…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: ESBA1008 Microvolume Study [Phase 2]
Phase 2 results for the ESBA1008 microvolume study in exudative age-related macular degeneration have been posted.